SPY - Novanta Inc. Buy-Ranked For Near Cap-Gains By Market-Makers
Investment Thesis
The investment thesis of this article is that a most important reason for investing in any stock is its potential for portfolio wealth-building and that requires informed forecasts of its likely future price. Novanta Inc. (NOVT) scores better now than most all other Medical Devices stocks for odds-on near price gain experiences, given today’s expectations by Market-Makers. While NOVT is not competitive with the top 20 ranked issues in the 2,700+ stock Market-Maker near-price forecasts population, many other Medical Device stocks also are even less-so.
Why Read This Report?
This is